nanoTherics
Private Company
Total funding raised: $2.3M
Overview
Founded in 2008, nanoTherics is a specialized provider of magnetic hyperthermia research equipment, primarily the magneTherm system. The company serves the global scientific community, enabling research in oncology, neuroscience, and drug delivery through its flexible, application-specific platforms. As a private company, it operates on a business-to-business (B2B) model, generating revenue from the sale of its instruments and accessories to research institutions worldwide. Its technology is cited in high-profile publications, validating its role as a key enabler in the magnetic nanoparticle research field.
Technology Platform
The magneTherm platform is a modular, bench-top instrumentation system for generating controlled alternating current (AC) magnetic fields (100 kHz - 1 MHz, up to 25 mT) used to heat magnetic nanoparticles. It enables a wide range of research applications including calorimetry, in vitro and in vivo studies, drug release, and neuronal stimulation through customizable coil configurations and accessories.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
nanoTherics positions itself as the leader in purpose-built systems for magnetic nanoparticle heating, contrasting with conventional induction heaters not optimized for biological research. While other specialized manufacturers may exist, the company's claims of being the global best-seller and its widespread adoption across top institutions suggest a dominant position in a specialized niche.